Hyperparathyroidism
1 paper
- Human trial1
Trial sponsors
Company1 trialPhase 4360 people
1 trialPhase 250 people
1 trialPhase 122 people
Funding
2 grants since 2023National Institute on AgingUS$4m
Vitamin D and beta-amyloid signaling in hyperparathyroidism
National Institute on AgingUniversity of California, San FranciscoUS$757k2023–2028
Cognitive Decline and Incident Dementia in Older Patients with Secondary Hyperparathyroidism
National Institute on AgingJohns Hopkins UniversityUS$806.5k2023–2028
Latest
1 in 12 monthsIndian Journal of Endocrinology and Metabolism
Obesity and Osteoporotic Fractures: Solving the Paradox
ReviewBones and joints
ENDO 2025 Abstract
SAT-798 Stronger Bones For A Stronger Life: Implementing Bone Health
Non-randomised trial in 314 peopleBones and joints
ENDO 2025 Abstract
SAT-777 Evaluation of FRAX in a U.S. Cohort of Primary Hyperparathyroidism
Cohort study of 4,288 peopleFRAX
European Journal of Endocrinology
EndoCompass project: research roadmap for calcium and bone endocrinology
ReviewIndustry & policy